XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment due to the adoption of ASU 2016-13
Common Stock
Additional Paid In Capital
Retained Earnings
Retained Earnings
Cumulative-effect adjustment due to the adoption of ASU 2016-13
Unearned ESOP Shares
Accumulated Other Comprehensive Income
Balance at beginning of period (in shares) at Jun. 30, 2020     17,021,357          
Balance at beginning of period at Jun. 30, 2020 $ 408,263 $ (13,358) $ 170 $ 169,648 $ 242,776 $ (13,358) $ (6,348) $ 2,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 23,083       23,083      
Cash dividends declared on common stock (3,734)       (3,734)      
Shares repurchased (in shares)     (566,455)          
Common stock repurchased (11,723)   $ (6) (11,717)        
Forfeited restricted stock (in shares)     (6,575)          
Retired stock (in shares)     (9,106)          
Retired stock $ (204)     (204)        
Granted restricted stock (in shares)     43,260          
Exercised stock options (in shares) 172,866   172,866          
Exercised stock options $ 2,490   $ 3 2,487        
Share-based compensation expense 1,449     1,449        
ESOP compensation expense 744     347     397  
Other comprehensive income (loss) (558)             (558)
Balance at end of period (in shares) at Mar. 31, 2021     16,655,347          
Balance at end of period at Mar. 31, 2021 406,452   $ 167 162,010 248,767   (5,951) 1,459
Balance at beginning of period (in shares) at Dec. 31, 2020     16,791,027          
Balance at beginning of period at Dec. 31, 2020 404,724   $ 168 166,352 242,182   (6,083) 2,105
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 7,869       7,869      
Cash dividends declared on common stock (1,284)       (1,284)      
Shares repurchased (in shares)     (289,333)          
Common stock repurchased (6,544)   $ (3) (6,541)        
Retired stock (in shares)     (8,473)          
Retired stock (195)     (195)        
Granted restricted stock (in shares)     43,260          
Exercised stock options (in shares)     118,866          
Exercised stock options 1,714   $ 2 1,712        
Share-based compensation expense 489     489        
ESOP compensation expense 325     193     132  
Other comprehensive income (loss) (646)             (646)
Balance at end of period (in shares) at Mar. 31, 2021     16,655,347          
Balance at end of period at Mar. 31, 2021 $ 406,452   $ 167 162,010 248,767   (5,951) 1,459
Balance at beginning of period (in shares) at Jun. 30, 2021 16,636,483   16,636,483          
Balance at beginning of period at Jun. 30, 2021 $ 396,519   $ 167 160,582 240,075   (5,819) 1,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 29,628       29,628      
Cash dividends declared on common stock (4,094)       (4,094)      
Shares repurchased (in shares)     (1,095,763)          
Common stock repurchased (32,318)   $ (11) (32,307)        
Forfeited restricted stock (in shares)     (12,000)          
Retired stock (in shares)     (11,335)          
Retired stock $ (345)     (345)        
Granted restricted stock (in shares)     40,123          
Stock issued for RSUs (in shares)     7,118          
Exercised stock options (in shares) 413,636   413,636          
Exercised stock options $ 6,081   $ 4 6,077        
Share-based compensation expense 1,407     1,407        
ESOP compensation expense 1,164     767     397  
Other comprehensive income (loss) $ (2,911)             (2,911)
Balance at end of period (in shares) at Mar. 31, 2022 15,978,262   15,978,262          
Balance at end of period at Mar. 31, 2022 $ 395,131   $ 160 136,181 265,609   (5,422) (1,397)
Balance at beginning of period (in shares) at Dec. 31, 2021     16,303,461          
Balance at beginning of period at Dec. 31, 2021 401,746   $ 163 147,552 258,986   (5,555) 600
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 8,023       8,023      
Cash dividends declared on common stock (1,400)       (1,400)      
Shares repurchased (in shares)     (419,931)          
Common stock repurchased (12,915)   $ (4) (12,911)        
Forfeited restricted stock (in shares)     (2,600)          
Retired stock (in shares)     (8,627)          
Retired stock (270)     (270)        
Granted restricted stock (in shares)     40,123          
Exercised stock options (in shares)     65,836          
Exercised stock options 1,039   $ 1 1,038        
Share-based compensation expense 507     507        
ESOP compensation expense 398     265     133  
Other comprehensive income (loss) $ (1,997)             (1,997)
Balance at end of period (in shares) at Mar. 31, 2022 15,978,262   15,978,262          
Balance at end of period at Mar. 31, 2022 $ 395,131   $ 160 $ 136,181 $ 265,609   $ (5,422) $ (1,397)